OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Health Politics Policy and Law is 1. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-11-01 to 2024-11-01.)

Article	Citations
Pandemic Politics: Timing State-Level Social Distancing Responses to COVID-19	221
No Equity without Data Equity: Data Reporting Gaps for Native Hawaiians and Pacific Islanders as Structural Racism	45
Lingering Legacies: Public Attitudes about Medicaid Beneficiaries and Work Requirements	33
Affordable but Inaccessible? Contraception Deserts in the US States	30
The Treatment of Disability under Crisis Standards of Care: An Empirical and Normative Analysis of Change over Time during COVID-19	17
Coping with Denialism: How Street-Level Bureaucrats Adapted and Responded to COVID-19 in Tanzania	15
Who Stays at Home? The Politics of Social Distancing in Brazil, Mexico, and the United States during the COVID-19 Pandemic	15
Fighting for America's Paradise: The Struggle against Structural Racism	15
Extending Postpartum Medicaid: State and Federal Policy Options during and after COVID-19	13
Who Counts Where? COVID-19 Surveillance in Federal Countries	13
Pursuing Pharmacoequity: Determinants, Drivers, and Pathways to Progress	13
The No Surprises Act: A Bipartisan Achievement to Protect Consumers from Unexpected Medical Bills	11
State Policies and Health Disparities between Transgender and Cisgender Adults: Considerations and Challenges Using Population-Based Survey Data	10
Compounding Racialized Vulnerability: COVID-19 in Prisons, Jails, and Migrant Detention Centers	10
The Political Economy of Market Power in Pharmaceuticals	9
Potemkin Protections: Assessing Provider Directory Accuracy and Timely Access for Four Specialties in California	9
Factors Affecting State-Level Enforcement of the Federal Mental Health Parity and Addiction Equity Act: A Cross-Case Analysis of Four States	9
Racism, Health, and Politics: Advancing Interdisciplinary Knowledge	9
The Line between Medicaid and Marketplace: Coverage Effects from Wisconsin's Partial Expansion	9
Hydroxychloroquine for COVID-19: Variation in Regional Political Preferences Predicted New Prescriptions after President Trump's Endorsement	8
Marketing Opioids to Veterans and Older Adults: A Content Analysis of Internal Industry Documents Released from State of Oklahoma v. Purdue Pharma LP, et al.	8
Improving Access to High-Value, High-Cost Medicines: The Use of Subscription Models to Treat Hepatitis C Using Direct-Acting Antivirals in the United States	8
Unsanitized and Unfair: How COVID-19 Bailout Funds Refuel Inequity in the US Health Care System	8
County-Level Segregation and Racial Disparities in COVID-19 Outcomes	7
The Future of State All-Payer Claims Databases	7

More Than Words? How Highlighting Target Populations Affects Public Opinion about the Medicaid Program	7
How Do Medicaid Agencies Improve Substance Use Treatment Benefits? Lessons from Three States' 1115 Waiver Experiences	7
Policy Responses to the Addiction Crisis	7
The Political Realignment of Health: How Partisan Power Shaped Infant Health in the United States, 1915–2017	7
Physician Trust in the News Media and Attitudes toward COVID-19	7
When Doctors strike: Making Sense of Professional Organizing in Kenya	6
Authoritarian Regime Legitimacy and Health Care Provision: Survey Evidence from Contemporary China	6
Regional International Organizations and Health: A Framework for Analysis	6
Inside ILSI: How Coca-Cola, Working through Its Scientific Nonprofit, Created a Global Science of Exercise for Obesity and Got It Embedded in Chinese Policy (1995–2015)	6
Technically Accessible, Practically Ineligible: The Effects of Medicaid Expansion Implementation on Chronic Homelessness	6
Americans' View of the Impact of COVID-19: Perspectives on Racial Impacts and Equity	6
Industry Payments to Physicians Are Kickbacks. How Should Stakeholders Respond?	6
Prescription Drug Priorities under the Biden Administration	5
Mexican-Origin Women's Construction and Navigation of Racialized Identities: Implications for Health Amid Restrictive Immigrant Policies	5
Entrenching Inequity, Eroding Democracy: State Preemption of Local Housing Policy	5
Negotiating Change: Ideas, Institutions, and Political Actors in Tobacco Control Policy Making in Mauritius	5
A Mixed-Methods Approach to Understanding the Disconnection between Perceptions of Abortion Acceptability and Support for Roe v. Wade among US Adults	5
A Draconian Law: Examining the Navigation of Coalition Politics and Policy Reform by Health Provider Associations in Karnataka, India	5
Undue Burdens: State Abortion Laws in the United States, 1994–2022	5
State Policy and Mental Health Outcomes under COVID-19	5
Intellectual Property and the Politics of Public Good during COVID-19: Framing Law, Institutions, and Ideas during TRIPS Waiver Negotiations at the WTO	5
Value-Based Insurance Design: Clinically Nuanced Consumer Cost Sharing to Increase the Use of High-Value Medications	5
What Is a “Racial Health Disparity”? Five Analytic Traditions	4
History and Politics of Medication Abortion in the United States and the Rise of Telemedicine and Self-Managed Abortion	4
Introduction to “Subnational COVID-19 Politics and Policy”	4
Trends in the Quality of Evidence Supporting FDA Drug Approvals: Results from a Literature Review	4
Introduction to “Recontextualizing Physician Associations: Revisiting Context, Scope, Methodology”	4
Introduction: The Politics of Abortion 50 Years afterRoe	4
The Conditional Effects of Health on Voter Turnout	4
Assessing US Pharmaceutical Policy and Pricing Reform Legislation in Light of European Price and Cost Control Strategies	4
Activism for Abortion Rights and Access Is Global: What the United States Can Learn from the Rest of the World	3
State Regulation and Hospital Community Benefit Spending in Medicaid Expansion States	3
Medicaid and Accelerated Approval: Spending on Drugs with and without Proven Clinical Benefits	3
Inside “Operation Change Agent”: Mallinckrodt's Plan for Capturing the Opioid Market	3
Reduction in Medicaid Rebates Paid by Pharmaceutical Manufacturers for Outpatient Infused, Injected, Implanted, Inhaled, or Instilled Drugs: The 5i Loophole	3
State Efforts to Regulate Provider Networks and Directories: Lessons for the Future	3
Prospects for Enforcing Prohibitions on Off-Label Drug Promotion after United States v. Caronia: An Analysis of Litigated Cases	3
State Courts, State Legislatures, and Setting Abortion Policy	3
The Link between Democratic Institutions and Population Health in the American States	3
International Reference Pricing in the Context of US Drug Policy	3
A Decade of ACOs in Medicare: Have They Delivered on Their Promise?	3
Self-Sourced Medication Abortion, Physician Authority, and the Contradictions of Abortion Care	3
“The CDC Won't Let Me Be”: The Opinion Dynamics of Support for CDC Regulatory Authority	3
The Rhetorical Transformations and Policy Failures of Prescription Drug Pricing Reform under the Trump Administration	3
Trajectories of Professional Authority: A Comparative Study of Medical Associations and Professional Authority Claims	3
The Bayh-Dole Act at 40: Accomplishments, Challenges, and Possible Reforms	3
The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies	3
How the Trump Administration's Pandemic Health Care Response Failed Racial Health Equity: Case Studies of Structural Racism and a Call for Equity Mindfulness in Federal Health Policy Making	2
Incentivizing COVID-19 Vaccination in a Polarized and Partisan United States	2
Centralization vs. Decentralization in COVID-19 Responses: Lessons from China	2

What Doctors Want: A Comment on the Financial Preferences of Organized Medicine	2
European Health Care Systems and the Emerging Influence of European Union Competition Policy	2
Medicare's Stewardship Role to Improve Care Delivery: Opportunities for the Biden Administration	2
Health Insurance Loss during COVID-19 May Increase Support for Universal Health Coverage	2
Medicare for All—Running Down a Dream	2
State Policies, Racial Disparities, and Income Support: A Way to Address Infant Outcomes and the Persistent Black-White Gap?	2
Pursuing Medicaid Block Grants with the Healthy Adult Opportunity Initiative: Dressing Up Old Ideas in New Clothes	2
Between the Waves: Building Power for a Public Option	1
Unlimited Discretion: How Unchecked Bureaucratic Discretion Can Threaten Abortion Availability	1
Awareness of COVID-19 at the Local Level: Perceptions and Political Consequences	1
Solidarity as a Political Determinant of Health: Insights from EU Competition Policy	1
Trust and Regulation: Assuring Scientific Independence in the FDA's Emergency Use Authorization Process	1
Relationship between Drug Overdose Mortality and Coverage of Drug-Related Issues in US Television Political Campaign Advertising in the 2012 and 2016 Election Cycles	1
The Impacts of Politicization on Public Health Workers: The COVID-19 Pandemic in Oregon and Montana	1
The Future of the Indispensable Insurer: The Biden Administration and Medicaid	1
Stabilizing and Strengthening the Affordable Care Act: Opportunities for a New Administration	1
Market Failure, State Failure: The Political Economy of Supply Chain Strengthening to Ensure Equitable Access to Vaccines and Medicines in Low- and Middle-Income Countries	1
Challenges with Defining Pharmaceutical Markets and Potential Remedies to Screen for Industry Consolidation	1
Political Partisanship, Trust, and Attitudes toward COVID-19 Vaccines in Indonesia	1
Polarization, the Pandemic, and Public Trust in Health System Actors	1
Abortion as a Public Health Risk in COVID-19 Antiabortion Legislation	1
Legislative and Regulatory Options for Improving Medicare Advantage	1
Insulin Shocks	1
Polarized Perspectives on Health Equity: Results from a Nationally Representative Survey on US Public Perceptions of COVID-19 Disparities in 2023	1
Expertise as a Response to Limited Multilateralism: The Case of South Korea's Vaccine Procurement Task Force for COVID-19 Vaccines amid Unequal Access via the COVAX Facility	1
Social Stigma and COVID-19 Vaccine Refusal in France	1
Federal Enforcement of Pharmaceutical Fraud under the False Claims Act, 2006–2022	1
Rationing by Inconvenience: How Insurance Denials Induce Administrative Burdens	1
Medicaid Home and Community-Based Services in the Wake of the COVID-19 Pandemic	1